Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma

Published:2017-10 Issue:10 Volume:39 Page:101042831772086
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumour Biol.

Author:

Hong Young Mi¹,Cho Mong¹,Yoon Ki Tae¹,Chu Chong Woo²,Yang Kwang Ho²,Park Yong Mok²,Rhu Je Ho²

Affiliation:

1. Department of Internal Medicine, College of Medicine Pusan National University, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea

2. Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, College of Medicine Pusan National University, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea

Publisher

IOS Press

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1010428317720863

Reference41 articles.

1. Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008

2. Hepatocellular carcinoma

3. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria

4. Hepatectomy for Hepatocellular Carcinoma: Toward Zero Hospital Deaths

5. Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation;Journal of Gastroenterology and Hepatology;2024-08-07

2. Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma;Nutrients;2024-03-25

3. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma;Scientific Reports;2024-03-04

4. Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives;Hepatobiliary Surgery and Nutrition;2024-02

5. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation;Meditsinskiy sovet = Medical Council;2024-01-17